Plasma S100 Calcium-Binding Protein A8/A9 and Cognitive Impairment After Acute Ischemic Stroke.

Key Points

• This research aims to explore the relationship between plasma S100A8/A9 levels and cognitive impairment after ischemic stroke.
• Measured plasma S100A8/A9 levels in patients with acute ischemic stroke
• Monitored the occurrence of post-stroke cognitive impairment (PSCI)
• Used statistical analysis to assess the correlation between S100A8/A9 levels and PSCI risk.
• Higher baseline plasma levels of S100A8/A9 correlated with increased risk of PSCI
• Identified S100A8/A9 as a potential predictive biomarker for PSCI

Abstract